echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetogia: GLP-1 receptor agonision lixisenatide lowers post-meal blood sugar for diabetics after full pancreatic excision.

    Diabetogia: GLP-1 receptor agonision lixisenatide lowers post-meal blood sugar for diabetics after full pancreatic excision.

    • Last Update: 2020-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The treatment of secondary diabetes remains a challenge after !---- whole pancreatic excision, and insulin is the only sugar-lowering treatment option for these patients.this study, it is assumed that the glucagon-like peptide 1 (GLP-1) receptor agonis lisisanite can improve post-meal glucose tolerance in patients with whole pancreatic excision.in a double-blind, randomized, cross-study, a total of 12 individuals who completely removed the pancreas after a single dose of 20?g lissila or a placebo (age: 65.0 x 9.5 average sD years; BMI: 22.9 x 3.9 kg / m2) and 12 healthy control individuals (66.1 x 7.6 years; BMI: 24.0 kg / m2) were tested for two three-hour liquid mixed meals (assessed gastric emptying with paracetamol).given underlying insulin the night before each experimental day;compared to placebo, lixisenatide reduced pancreatic excision group (baseline-subtracted AUC (bsAUC) (mean?SEM) : 548 s 125 vs 1447 x min, p.lt; 0.001) and control group (?126.12.222.51 mmol/l,pancreatic excision group had an average peak glucose concentration of 23.3 to 1.0 mmol / l in the 134-11 min group, while in the placebo group it was 18 x 1.4 mmol / l (p - 0.008) Lisilla for 148 to 13 minutes (p . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .in the control group, the average peak concentration of placebo at 70?13 min was 8.2 to 0.4 mmol / l, while the average peak concentration at the 8-hour point was 5.5 to 0.1 mmol / l (p.lt;0.001).25 minutes with Lisilla (p s li0.054).in the pancreatic excision group (66-group84 vs 1190-311 pmol / l x min, p - 0.008) and control group (141 x 100 vs 190 x 100 pmol / l x min, Lissesenatide also reduced the reaction of gastric draining and post-meal hyperglycemia, p. 0.034).c peptides were not detected in the plasma in the pancreatic group.control group, the post-meal plasma c peptide reaction was reduced with lisesiniti (18 x 17 vs 189 x 31 nmol/l x min, p.lt; 0.001).results showed that GLP-1 receptor agonists lixisenatide reduced the increase in blood sugar after meals in patients with whole pancreatic excision.its modes of action seem to include a slower rate of gastric emptying and a decrease in post-meal reactions of the visceral source glucagon..
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.